- Home
- CADL vs EFR Comparison
CADL vs EFR Comparison
Compare CADL & EFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- EFR
- Stock Information
- Founded
- CADL 1999
- EFR 2003
- Country
- CADL United States
- EFR United States
- Employees
- CADL N/A
- EFR N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- EFR Trusts Except Educational Religious and Charitable
- Sector
- CADL Health Care
- EFR Finance
- Exchange
- CADL Nasdaq
- EFR Nasdaq
- Market Cap
- CADL 313.5M
- EFR 344.0M
- IPO Year
- CADL 2021
- EFR N/A
- Fundamental
- Price
- CADL $4.79
- EFR $11.65
- Analyst Decision
- CADL Strong Buy
- EFR
- Analyst Count
- CADL 5
- EFR 0
- Target Price
- CADL $19.80
- EFR N/A
- AVG Volume (30 Days)
- CADL 724.9K
- EFR 88.6K
- Earning Date
- CADL 08-14-2025
- EFR 01-01-0001
- Dividend Yield
- CADL N/A
- EFR 9.43%
- EPS Growth
- CADL N/A
- EFR N/A
- EPS
- CADL N/A
- EFR 1.69
- Revenue
- CADL N/A
- EFR N/A
- Revenue This Year
- CADL N/A
- EFR N/A
- Revenue Next Year
- CADL N/A
- EFR N/A
- P/E Ratio
- CADL N/A
- EFR $7.74
- Revenue Growth
- CADL N/A
- EFR N/A
- 52 Week Low
- CADL $3.79
- EFR $10.95
- 52 Week High
- CADL $14.60
- EFR $13.29
- Technical
- Relative Strength Index (RSI)
- CADL 32.97
- EFR 41.61
- Support Level
- CADL $4.81
- EFR $11.10
- Resistance Level
- CADL $5.01
- EFR $11.75
- Average True Range (ATR)
- CADL 0.30
- EFR 0.11
- MACD
- CADL -0.08
- EFR 0.00
- Stochastic Oscillator
- CADL 3.18
- EFR 82.09
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About EFR Eaton Vance Senior Floating-Rate Fund of Beneficial Interest
Eaton Vance Senior Floating Rate Trust is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income. As a secondary objective, the fund intends to seek capital preservation. Its portfolio of investments consists of Software, Health Care Providers & Services, Machinery, Chemicals, Professional Services, IT Services, Hotels, Restaurants & Leisure, Capital Markets, Specialty Retail, Commercial Services & Supplies, and other areas. The trust invests in below investment grade floating rate loans, which are considered speculative because of the credit risk of their issuers.